For the aspect of mutually concurrent and exclusive genes, in the young lung cancer group, there were genes significantly concurrent with actionable driver genes (EGFR, KRAS, ARID1A: TP53 and RB1 with EGFR; PIK3CA with KRAS and ARID1A (Figure 3B). This evidence concerns the gene KRAS and lung carcinoma.